- Home
- Publications
- Publication Search
- Publication Details
Title
Blood biomarkers and treatment response in major depression
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 18, Issue 6, Pages 513-529
Publisher
Informa UK Limited
Online
2018-04-27
DOI
10.1080/14737159.2018.1470927
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations
- (2018) Amanda J. Lisoway et al. NEUROSCIENCE LETTERS
- Effect of antidepressant treatment on peripheral inflammation markers – A meta-analysis
- (2018) Magdalena Więdłocha et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response
- (2017) Laura M Fiori et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Inflammation-induced depression: Its pathophysiology and therapeutic implications
- (2017) Sang Won Jeon et al. JOURNAL OF NEUROIMMUNOLOGY
- Research progress on the roles of microRNAs in governing synaptic plasticity, learning and memory
- (2017) Chang-Wei Wei et al. LIFE SCIENCES
- Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis
- (2017) Cristiano A. Köhler et al. MOLECULAR NEUROBIOLOGY
- An integrative review of methylation at the serotonin transporter gene and its dialogue with environmental risk factors, psychopathology and 5-HTTLPR
- (2017) H. Palma-Gudiel et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Neurobiology of local and intercellular BDNF signaling
- (2017) Manju Sasi et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Is C-reactive protein ready for prime time in the selection of antidepressant medications?
- (2017) Andrew H. Miller et al. PSYCHONEUROENDOCRINOLOGY
- MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes
- (2017) Juan Pablo Lopez et al. Nature Communications
- Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry
- (2017) Azmeraw T. Amare et al. EPMA Journal
- Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression
- (2017) Chanjuan Zhou et al. PLoS One
- Seeking an objective diagnosis of depression
- (2016) John A Bilello Biomarkers in Medicine
- Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort
- (2016) Raymond W. Lam et al. BMC Psychiatry
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
- (2016) Sidney H. Kennedy et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions
- (2016) Veronica Begni et al. CLINICAL SCIENCE
- Evaluation of interleukin-6 and serotonin as biomarkers to predict response to fluoxetine
- (2016) Aarthi Manoharan et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Alterations of microRNA-124 expression in peripheral blood mononuclear cells in pre- and post-treatment patients with major depressive disorder
- (2016) Shen He et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Metabolomics enables precision medicine: “A White Paper, Community Perspective”
- (2016) Richard D. Beger et al. Metabolomics
- TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics
- (2016) M Gupta et al. MOLECULAR PSYCHIATRY
- Molecular biomarkers of depression
- (2016) Anand Gururajan et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- MicroRNAs and psychiatric disorders: From aetiology to treatment
- (2016) Alessia Luoni et al. PHARMACOLOGY & THERAPEUTICS
- Pathogenetic and therapeutic applications of microRNAs in major depressive disorder
- (2016) Yogesh Dwivedi PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Circulating Plasma Micro RNAs in Patients with Major Depressive Disorder Treated with Antidepressants: A Pilot Study
- (2016) Virgil Radu Enatescu et al. Psychiatry Investigation
- Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients
- (2016) Nazan Yuce-Artun et al. International Journal of Clinical Pharmacy
- Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression
- (2016) L M Williams et al. Translational Psychiatry
- Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants
- (2016) D M Rotroff et al. Translational Psychiatry
- The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders
- (2016) A Cattaneo et al. Translational Psychiatry
- Plasma Metabolites Predict Severity of Depression and Suicidal Ideation in Psychiatric Patients-A Multicenter Pilot Analysis
- (2016) Daiki Setoyama et al. PLoS One
- Tobacco Consumption Concerns With the Use of CYP1A2 Metabolized Antidepressants
- (2015) Florence Gressier et al. AMERICAN JOURNAL OF PSYCHIATRY
- ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial
- (2015) Alan F. Schatzberg et al. AMERICAN JOURNAL OF PSYCHIATRY
- Serum Interleukin-6 Is a Predictive Biomarker for Ketamine’s Antidepressant Effect in Treatment-Resistant Patients With Major Depression
- (2015) Jian-jun Yang et al. BIOLOGICAL PSYCHIATRY
- Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
- (2015) Rita Haapakoski et al. BRAIN BEHAVIOR AND IMMUNITY
- Inflammatory Biomarkers as Differential Predictors of Antidepressant Response
- (2015) Kenji Hashimoto INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients
- (2015) Romain Colle et al. JOURNAL OF AFFECTIVE DISORDERS
- Shank3 as a potential biomarker of antidepressant response to ketamine and its neural correlates in bipolar depression
- (2015) Robin Ortiz et al. JOURNAL OF AFFECTIVE DISORDERS
- BDNF as a biomarker for successful treatment of mood disorders: A systematic & quantitative meta-analysis
- (2015) Maryna Polyakova et al. JOURNAL OF AFFECTIVE DISORDERS
- Epigenetics of Stress-Related Psychiatric Disorders and Gene × Environment Interactions
- (2015) Torsten Klengel et al. NEURON
- Genetic variation in IL-1β, IL-2, IL-6, TSPO and BDNF and response to duloxetine or placebo treatment in major depressive disorder
- (2015) Malgorzata Maciukiewicz et al. PHARMACOGENOMICS
- Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine
- (2015) Nils C. Gassen et al. Science Signaling
- New hypothesis and treatment targets of depression: an integrated view of key findings
- (2015) Shangli Cai et al. Neuroscience Bulletin
- Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine
- (2015) Nils C. Gassen et al. Science Signaling
- Prediction of treatment outcomes in major depressive disorder
- (2015) Boadie W Dunlop Expert Review of Clinical Pharmacology
- An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline
- (2014) Rudolf Uher et al. AMERICAN JOURNAL OF PSYCHIATRY
- Brain-derived neurotrophic factor Val66Met polymorphism association with antidepressant efficacy: A systematic review and meta-analysis
- (2014) Tingting Yan et al. Asia-Pacific Psychiatry
- BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: Results from a factorial, randomized, sham-controlled trial
- (2014) André R. Brunoni et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response
- (2014) Katharina Domschke et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The potential of SLC6A4 gene methylation analysis for the diagnosis and treatment of major depression
- (2014) Satoshi Okada et al. JOURNAL OF PSYCHIATRIC RESEARCH
- miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment
- (2014) Juan Pablo Lopez et al. NATURE MEDICINE
- The Genetics of Major Depression
- (2014) Jonathan Flint et al. NEURON
- MicroRNA 135 Is Essential for Chronic Stress Resiliency, Antidepressant Efficacy, and Intact Serotonergic Activity
- (2014) Orna Issler et al. NEURON
- Significantly decreased mRNA levels of BDNF and MEK1 genes in treatment-resistant depression
- (2014) Wu Hong et al. NEUROREPORT
- Antidepressant treatment response is modulated by genetic and environmental factors and their interactions
- (2014) Dávid Kovacs et al. Annals of General Psychiatry
- Effects of genetic and early environmental risk factors for depression on serotonin transporter expression and methylation profiles
- (2014) M Wankerl et al. Translational Psychiatry
- Pharmacogenetics of antidepressant drugs: An update after almost 20 years of research
- (2013) Chiara Fabbri et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
- (2013) John H. Krystal et al. BIOLOGICAL PSYCHIATRY
- Biomarkers Predicting Antidepressant Treatment Response: How Can We Advance the Field?
- (2013) Christiana Labermaier et al. DISEASE MARKERS
- Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder
- (2013) Reiji Yoshimura et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression
- (2013) Chee Ng et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression
- (2013) A Tadić et al. MOLECULAR PSYCHIATRY
- BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression
- (2013) Greer M. Murphy et al. Pharmacogenetics and Genomics
- Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting
- (2013) Daniel K. Hall-Flavin et al. Pharmacogenetics and Genomics
- Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway
- (2013) Hongjie Zhu et al. PLoS One
- Pharmacogenetics in major depression: A comprehensive meta-analysis
- (2013) Tomihisa Niitsu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Association of SLC6A4 methylation with early adversity, characteristics and outcomes in depression
- (2013) Hee-Ju Kang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine
- (2013) Philip T. Ninan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo
- (2013) R Kaddurah-Daouk et al. Translational Psychiatry
- DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP
- (2013) T R Powell et al. Translational Psychiatry
- Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance
- (2012) Matteo Martino et al. Current Neuropharmacology
- Current status and future prospects for epigenetic psychopharmacology
- (2012) Marco P. Boks et al. Epigenetics
- Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response
- (2012) Timothy R. Powell et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Gene × environment interactions in the prediction of response to antidepressant treatment
- (2012) Torsten Klengel et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Neurotrophin regulation of neural circuit development and function
- (2012) Hyungju Park et al. NATURE REVIEWS NEUROSCIENCE
- Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors’ and Longitudinal ‘Targets’
- (2012) Annamaria Cattaneo et al. NEUROPSYCHOPHARMACOLOGY
- Merging pharmacometabolomics with pharmacogenomics using ‘1000 Genomes’ single-nucleotide polymorphism imputation
- (2012) Ryan Abo et al. Pharmacogenetics and Genomics
- Epigenetic Mechanisms of Depression and Antidepressant Action
- (2011) Vincent Vialou et al. Annual Review of Pharmacology and Toxicology
- Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism
- (2011) Stefano Porcelli et al. Expert Opinion on Drug Metabolism & Toxicology
- Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression
- (2011) Yang Liu et al. JOURNAL OF AFFECTIVE DISORDERS
- Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims
- (2011) Ghanshyam N. Pandey et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study
- (2011) G I Papakostas et al. MOLECULAR PSYCHIATRY
- The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
- (2011) Jonas Hannestad et al. NEUROPSYCHOPHARMACOLOGY
- Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters
- (2011) Scott T. Younger et al. NUCLEIC ACIDS RESEARCH
- Gene–Environment Interaction in Major Depression and Antidepressant Treatment Response
- (2011) Robert Keers et al. Current Psychiatry Reports
- Association analysis between variants of the interleukin-1β and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression
- (2011) Andre Tadic Neuropsychiatric Disease and Treatment
- Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16
- (2011) J M Launay et al. Translational Psychiatry
- Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept
- (2011) R Kaddurah-Daouk et al. Translational Psychiatry
- Genome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project
- (2010) Rudolf Uher et al. AMERICAN JOURNAL OF PSYCHIATRY
- Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics-Informed Pharmacogenomics
- (2010) Y Ji et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression
- (2010) Jane E. Sarginson et al. Pharmacogenetics and Genomics
- Association between CYP2C19*17 and metabolism of amitriptyline, citalopram and clomipramine in Dutch hospitalized patients
- (2010) A de Vos et al. PHARMACOGENOMICS JOURNAL
- MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants
- (2010) A. Baudry et al. SCIENCE
- Biomarkers to Predict Antidepressant Response
- (2010) Andrew F. Leuchter et al. Current Psychiatry Reports
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
- (2009) Andrew H. Miller et al. BIOLOGICAL PSYCHIATRY
- The Interleukin 1 Beta (IL1B) Gene Is Associated with Failure to Achieve Remission and Impaired Emotion Processing in Major Depression
- (2009) Bernhard T. Baune et al. BIOLOGICAL PSYCHIATRY
- Effect of Cytochrome P450 2D6 Genotype on Maternal Paroxetine Plasma Concentrations during Pregnancy
- (2009) F.F. Tessa Ververs et al. CLINICAL PHARMACOKINETICS
- An operational definition of epigenetics
- (2009) S. L. Berger et al. GENES & DEVELOPMENT
- Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment
- (2009) Annamaria Cattaneo et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Epigenetic side-effects of common pharmaceuticals: A potential new field in medicine and pharmacology
- (2009) Antonei B. Csoka et al. MEDICAL HYPOTHESES
- Metabolomics tools for identifying biomarkers for neuropsychiatric diseases
- (2009) Marlon P. Quinones et al. NEUROBIOLOGY OF DISEASE
- Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: Results of the BRITE-MD study
- (2009) Andrew F. Leuchter et al. PSYCHIATRY RESEARCH
- Metabolomics: A Global Biochemical Approach to Drug Response and Disease
- (2008) Rima Kaddurah-Daouk et al. Annual Review of Pharmacology and Toxicology
- A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
- (2008) André Russowsky Brunoni et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The implications of gene–environment interactions in depression: will cause inform cure?
- (2008) R Uher MOLECULAR PSYCHIATRY
- Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression
- (2008) Manfred Uhr et al. NEURON
- Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
- (2008) Arzu Gunes et al. PHARMACOGENOMICS
- Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
- (2007) Triin Eller et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started